ReviewJACC. Asia2026
Improving Polygenic Risk Prediction for Atherosclerotic Cardiovascular Disease in East Asian Populations.
Review in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genetic predisposition contributes substantially to the risk for atherosclerotic cardiovascular disease (ASCVD). Polygenic risk scores (PRS), which quantify this inherited susceptibility, have demonstrated strong predictive performance in European populations, with accumulating evidence supporting their use in clinical practice. However, East Asian populations face a notable gap in PRS development and validation, with limited studies guiding their clinical application. In this state-of-the-art review, the authors summarize current evidence on PRS for coronary artery disease and ischemic stroke, the 2 major subtypes of ASCVD, in East Asian populations. The authors place specific focus on cross-ancestry integration strategies and key methodological considerations to enhance predictive accuracy. Additionally, the authors highlight the clinical utility of ASCVD PRS in primary and secondary prevention and their evaluation in real-world settings and outline strategies for clinical translation into routine care for East Asians. This review underscores the need for initiatives to facilitate the application of PRS across diverse populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.